employment

Worse Work Status in MS Tied to Subjective Cognitive Impairment

Patient-reported cognition difficulties ā€” called subjective cognitive impairment (SCI) ā€” are associated with current work status and with employment deterioration after two years in people with multiple sclerosis (MS), a new study reports. Depression and anxiety also were linked with work status among these MS patients, but such…

She Disclosed Her Illness and Got the Job

It’s a decision most of us with a chronic illness have to make sooner or later: When do we disclose our illness, and to whom, and how do we do it? Thirty-one-year-old Katie Coleman faced that decision not long ago. Coleman has stage 4 kidney cancer, and, in April, she…

You’ve Got to Hide Your MS Away

In honor of MS Awareness Week, observed in the U.K. April 19ā€“25, the MS Society released results of a survey about the barriers that keep multiple sclerosis patients from sharing their health status. Multiple Sclerosis News Today‘s Mary Chapman reportedĀ that a whacking one-third have stayed silent about their diagnosis.

Employed MS Patients Have Lower Productivity, Reduced Health-related Quality of Life, Study Shows

Employed individuals with relapsing-remitting multiple sclerosis (RRMS) have lower work productivity, reduced health-related quality of life, and use more healthcare resources than individuals who do not have multiple sclerosis (MS), a new study shows. The study, ā€œBurden of relapsing-remitting multiple sclerosis on workers in the US: a cross-sectional…

October Is National Disability Employment Awareness Month

Everything can be more challenging when you have a disability, and being part of the workforce can add even more challenges. The month of October is National Disability Employment Awareness Month (NDEAM), and according toĀ the U.S. Department of Laborā€™s website, this year’s theme is ā€œAmericaā€™s Workforce: Empowering All.ā€…

Truly ‘Benign MS’ Evident in Only Small Minority of Patients, Large UK Study Reports

Multiple sclerosis (MS)Ā that appears to be "genuinely benign" 15 years after diagnosis is evident in a small number of patients, a large population-based study from the U.K. reports. But, its researchers note, the term ā€œbenignā€ is often not clinically accurate as used, because it is based largely on perceptions of disease impact. The study ā€œHow common is truly benign MS in a UK population?ā€ was published in the Journal of Neurology, Neurosurgery & Psychiatry. The concept of benign MS is controversial, especially among clinicians. Still, long-term epidemiological studies have consistently identified a small fraction of patients whose MS progresses very slowly over a long span of years. Determining the prevalence of this type of MS in the population has been difficult, as estimates can vary significantly depending of the definition of ā€œbenignā€ that is adopted. Researchers sought to determine an accurate estimate of benign MS in the U.K. population, using a rigorous and comprehensive clinical definition of a truly benign disease. This definition included minimal physical disability (EDSS scoreĀ of less than 3), and no significant fatigue, mood disturbance, cognitive impairment or interrupted employment in the absence of treatment with disease-modifying therapies over 15 years or more years after symptom onset. They screened an U.K. population-based registry containing data on 3,062 MS patients to identify those with "unlimited walking ability" 15 or more years after diagnosis. A representative sample of 60 patients Ā from this pool was analyzed (45 women and 15 men, mean age of 57); they had a mean disease duration of 28 years. Nine out of these 60 (15%; 8 women and one men) fulfilled the studyā€™s criteria for truly benign disease. These nine people had a mean age of 27 at symptom onset, a median EDSS disability score of 1.5 (minimal signs of disability), and a mean disease duration of 31 years. "Those nine individuals with truly benign MS all remained in a relapsingā€“remitting state," the study noted. "However, only two out of nine showed disease arrest within the first decade; the remainder all continued to experience relapses well into their second or third decade of MS," but the rates of such relapses were low. MS in the remaining patients was not classified as benign, mostly due to evidence of cognitive difficulties (57%), and the disease's impact on employment status (52%) with many taking early retirement. Based on these results, a population frequency for "benign MS" under the definitions used was estimated at 2.9%. But the researchers noted that a large proportion of patients (65%; 39 patients out of 60) reported their disease as benign, according to a lay definition. Their self-reported status poorly agreed with the clinical assessments done throughout the study. "There is no accepted definition to offer patients when exploring whether they feel their MS is benign; the definition we chose incorporates the fundamental principles of low impact on a person, absence of complications and a favourable outcome and is in line with definitions provided by third-party support groups," the researchers wrote. Many Ā considering themselves with benign disease did so based on their "perception" of their disease, the team added, and one that "appeared to be driven as much by mood, fatigue and bladder function as by physical ability."Ā  ā€œIn conclusion, after detailed clinical assessment, a small minority of people with MS appear genuinely unaffected by symptoms after 15 years,ā€ the researchers added. They also called attention to the fact that EDSS-based definitions of benign MS and the inconsistency between patient and clinician perception of benign MS compromise the use of the term ā€˜benignā€™ in clinical practice. They also emphasize that studying individuals with benign MS ā€œhas the potential to uncover clues to mechanisms underlying favorable outcomes in MS, provide insights into new therapeutic targets and have implications for patient counselling, individual patient management and the construct of clinical trials.ā€

#ECTRIMS2016 – Cognitive Problems in MS Patients Linked to Lower Income, Study Reports

In a recent talk, titled ā€œIncome and cognitive impairment among multiple sclerosis patients,ā€ scientists investigated how cognitive impairmentĀ impacts the life of patients with multiple sclerosis (MS), and reported significant differences in incomeĀ that correlated with levels of MS-cognitive deficit. These findingsĀ were recently presented at the 32nd Congress of theĀ European Committee for…